MLICM
PSDO

Metropolitan Life Insurance Company (MetLife)’s Presidio, Inc. Common Stock PSDO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio PSDO Stock Details PSDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15,250
Closed -$258K – 2596
2019
Q3 		$258K Buy
15,250
+2,608
+21% +$38.9K ﹤0.01% 1705
2019
Q2 		$173K Hold
12,642
– – ﹤0.01% 1987
2019
Q1 		$187K Hold
12,642
– – ﹤0.01% 1939
2018
Q4 		$165K Buy
12,642
+3,500
+38% +$48.5K ﹤0.01% 1942
2018
Q3 		$139K Sell
9,142
-3,989
-30% -$59.1K ﹤0.01% 2255
2018
Q2 		$172K Buy
13,131
+4,324
+49% +$62.9K ﹤0.01% 2044
2018
Q1 		$138K Buy
8,807
+799
+10% +$13.3K ﹤0.01% 2123
2017
Q4 		$154K Sell
8,008
-9,725
-55% -$153K ﹤0.01% 2063
2017
Q3 		$251K Sell
17,733
-511
-3% -$7.06K ﹤0.01% 2152
2017
Q2 		$261K Buy
+18,244
New +$275K ﹤0.01% 2175

Metropolitan Life Insurance Company (MetLife)'s PSDO Position: Q4 2019 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Presidio, Inc. Common Stock (PSDO) in Q4 2019, closing a stake of 15,250 shares — an estimated $258K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PSDO in Q2 2017 and held it in 10 quarters. The position peaked at $261K in Q2 2017. 0 funds tracked by Wall St. Rank hold PSDO as of Q4 2019.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Presidio, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 15,250 Presidio, Inc. Common Stock shares in Q4 2019, an estimated $258K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Presidio, Inc. Common Stock in Q2 2017 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Presidio, Inc. Common Stock position peaked at $261K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Presidio, Inc. Common Stock as of Q4 2019.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2019, filed 14 Feb 2020.